CALGB 50803 (Alliance): A phase II trial of lenalidomide plus rituximab in patients with previously untreated follicular lymphoma
      Google Scholar   
Citation:
J Clin Oncol vol 32 (15 suppl) abstr 8521
Meeting Instance:
ASCO 2014
Year:
2014
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
2762  
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                     
Networks:
 
Study
CALGB-50803
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: